An anti-inflammatory drug called dexamethasone has been hailed as a ground-breaking treatment for hospital patients seriously ill with Covid-19. A UK trial showed the drug could save lives - the ...
A life-saving treatment for seriously-ill hospital patients with Covid-19 is being used across the UK from today, following breakthrough results in a UK trial. Dexamethasone - a cheap, widely ...
Currently, the drug dexamethasone is still the only therapeutic shown to be effective against the novel coronavirus for severe patients, the chief of the World Health Organization said Friday.
Remdesivir plus dexamethasone vs dexamethasone alone reduces the risk of mortality among patients hospitalized with COVID-19.
European regulators have begun a speedy review of dexamethasone as a treatment for adults hospitalised with COVID-19, a potentially cheaper option to aid recovery than Gilead’s Veklury.
PETALING JAYA: Dexamethasone, which is used for pneumonia patients, is more effective in treating Covid-19 than remdesivir and the HIV/AIDS drugs lopinavir or ritonavir, says Health director ...
Dexamethasone has become the drug of choice for treating severely ill coronavirus patients in Kenyan hospitals. The first clinical study to be published by the Ministry of Health on the treatment ...
Dexamethasone has improved survival rates in hospitalized COVID-19 patients. More targeted anti-cytokine approaches, using monoclonal antibodies against the cytokines Interleukin-1 (IL-1 ...
For the sickest individuals, doctors can prescribe dexamethasone, a cheap steroid that's been shown to significantly reduce mortality among critically ill COVID-19 patients. A recent analysis from ...
Al-Monitor is an award-winning media outlet covering the Middle East, valued for its independence, diversity and analysis. It is read widely by US, international and Middle East decision makers at the ...
MOSCOW, June 1. /TASS/. Dexamethasone, a drug used by the UK medics, is not a breakthrough in treatment of the coronavirus, the drug panacea for this infection has not been created yet ...